Table 2.
Patient Characteristics at Enrollment (N = 191)
| Characteristic | Value |
|---|---|
| Female sex, % (no./total) | 49.2 (94/191) |
| Age, median (IQR), y | 47 (34–61) |
| Medical history, % (no./total) | |
| Lung disease | 12.6 (24/191) |
| Cancer | 13.6 (26/191) |
| Diabetes | 26.7 (51/191) |
| Immunosuppression | 7.3 (14/191) |
| Heart disease | 11.0 (21/191) |
| Hypertension | 36.6 (70/191) |
| ACEI/ARB use | 18.3 (35/191) |
| Stroke | 4.2 (8/191) |
| Dementia | 4.7 (9/191) |
| DVT/PE | 5.8 (11/191) |
| Chronic kidney disease | 9.9 (19/191) |
| Smoking | 20.9 (40/191) |
| Symptoms at presentation, % (no./total) | |
| Fever | 64.4 (123/191) |
| Chills | 31.4 (60/191) |
| Cough | 67.5 (129/191) |
| Sore throat | 16.2 (31/191) |
| Congestion | 8.4 (16/191) |
| Shortness of breath | 63.4 (121/191) |
| Chest pain | 34.6 (66/191) |
| Myalgia | 34.6 (66/191) |
| Nausea, vomiting, or diarrhea | 40.8 (78/191) |
| Loss of taste | 38.7 (74/191) |
| Loss of smell | 27.2 (52/191) |
| Confusion | 2.6 (5/191) |
| Headache | 26.2 (50/191) |
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; DVT, deep vein thrombosis; IQR, interquartile range; PE, pulmonary embolus.